Mesure d'audience ROI frequentation par
About Hybrigenics
Investors Relations
Infos - Médias
Careers
Contact Us
This option will not work correctly. Unfortunately, your browser does not support Inline Frames
2009 Turnover and Revenues:
Growth of +15%
Hybrigenics wins a $ 2.1 million yeast two-hybrid contract
Hybrigenics unveils a lead chemical structure for its discovery of new anticancer drugs
New Hybrigenics patent application for high-yield inecalcitol production
Investors
Contact Us
Glossary
Site Map
Legal Mentions
English
Français
© 2010 hybrigenics